Obermatt
See Similar Stocks →

Elicio Therapeutics

NAQ:ELTX · US28657F1030
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings58
Price/Book89
Dividend Yield—
Revenue Growth—
Profit Growth89
Capital Growth44
TSR 52w63
Leverage1
Liquidity74
Refinancing41
Combined—
Analyst Opinions100
Pro Holdings9
Opinion Changes50
Market Pulse42

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Employees44
Websiteelicio.com
ISINUS28657F1030
Last UpdateApr 2, 2026
Index & Theme
ImmunologyVaccinesStem Cell TherapyOncologyBiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Description

Elicio Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company is pioneering the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The company's proprietary…

Similar Stocks

The companies this stock is ranked against.

Compare Elicio Therapeutics with its peers
PMV Pharmaceuticals
NSQ:PMVP
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Syndax Pharmaceuticals
NSQ:SNDX
59
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zymeworks
NSQ:ZYME
43
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
BridgeBio Oncology Therapeutics
NMQ:BBOT
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Design Therapeutics
NSQ:DSGN
71
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Verastem
NAQ:VSTM
56
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →